Prevalence of hepatitis G virus in Queensland blood donors

Med J Aust. 1996 Oct 7;165(7):369-71. doi: 10.5694/j.1326-5377.1996.tb125019.x.

Abstract

Objective: To determine the prevalence of hepatitis G virus (HGV) carriage in Queensland blood donors.

Design: Cross-sectional survey with retrospective longitudinal study of HGV-positive donors.

Setting: Brisbane Red Cross Blood Bank, 1995.

Subjects: 100 consecutive blood donors attending the Blood Bank on two days in October 1995 and 20 blood donors with a raised plasma alanine aminotransferase (ALT) level on their last donation.

Outcome measures: Presence of HGV RNA by reverse transcription polymerase chain reaction (RT-PCR) in currently donated blood and in blood samples archived for up to 34 months. RT-PCR used two different reverse transcription methods and three different specific sets of primers and probes.

Results: Five of the 120 blood donors were positive for HGV RNA by all RT-PCR methods (four of the 100 with normal ALT levels [4%] and one of the 20 with raised ALT levels [5%]). Retrospective testing of archived samples showed that four of these five had been persistently HGV RNA-positive for at least two years, while the fifth had been HGV RNA-negative on two donations before becoming HGV RNA-positive. No risk factors were identified for this donor.

Conclusions: A relatively large number of Queensland blood donors (4%) are persistently HGV RNA-positive.

MeSH terms

  • Adult
  • Alanine Transaminase / blood
  • Blood Donors / statistics & numerical data*
  • Carrier State / blood
  • Carrier State / epidemiology*
  • Carrier State / immunology
  • Cross-Sectional Studies
  • Female
  • Flaviviridae* / genetics
  • Hepatitis B Antibodies / blood
  • Hepatitis C Antibodies / blood
  • Hepatitis, Viral, Human / blood
  • Hepatitis, Viral, Human / epidemiology*
  • Hepatitis, Viral, Human / immunology
  • Humans
  • Male
  • Polymerase Chain Reaction / methods
  • Prevalence
  • Queensland / epidemiology
  • RNA, Viral / blood
  • Retrospective Studies
  • Transcription, Genetic

Substances

  • Hepatitis B Antibodies
  • Hepatitis C Antibodies
  • RNA, Viral
  • Alanine Transaminase